Biggest News Aggregation in the World
📰 Ocast Report News

Ocast Report News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ocast Report. Real-time updates on events, politics, business and more.

Roche receives FDA approval of label expansion for VENTANA PD-L1 (SP263) Assay to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo

/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the VENTANA PD-L1 (SP263)...
United States Jo Lynn Garing World Health Organization Drug Administration Roche Molecular Systems Inc Head Of Pathology Lab

Roche's VENTANA PD-L1 (SP263) Assay receives CE IVD approval to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo

The VENTANA PD-L1 (SP263) Assay helps determine which patients with non-small cell lung cancer may be eligible for treatment with Libtayo monotherapy1 based on...
United States Jo Lynn Garing World Health Organization European Commission Head Of Pathology Lab At Roche Diagnostics Roche Diagnostics Communications

Triton Digital Releases November 2021 U.S. Podcast Report, Stitcher Media Leads

TRITON DIGITAL has released the latest U.S. POCAST REPORT for the NOVEMBER 2021 reporting period as measured by its PODCAST METRICS measurement service.STITCHER MEDIA remained in the #1 spot on the TOP NETWORKS REPORT with 40.3m Average Weekly Downloads and 11.1m Average Weekly Users, followed by, NPR with 31.1m Average Weekly Downloads and 6.8m Average Weekly Users, and AUDACY PODCAST NETWORK with 30.9m Average Weekly Downloads and 9.1m Average Weekly Users.The top three podcasts include NPR .....
Will Ferrell Roy Trakin Thing About Triton Digital Releases November Stitcher Media Average Weekly Downloads

IMFINZI Demonstrated Unprecedented Survival in Unresectable Stage III Lung Cancer With 43% Of Patients Surviving Five Years

Long-term data from PACIFIC Phase III trial at ASCO showed 33% of patients remained progression-free at five years Longest-ever survival reported in a Phase III immunotherapy trial in this setting ...
United States Dave Fredrickson Daiichi Sankyo David Spigel Company On Twitter Astrazeneca American Society Of Clinical Oncology

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science